Evidence map›Paper›PMID 33413981›Full record

ArticleBreast (Edinburgh, Scotland)2021

Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany".

Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W Beckmann, Erik Belleville, Peter A Fasching, Tanja N Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji and 24 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast (Edinburgh, Scotland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Andreas SchneeweissNational Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Johannes EttlDepartment of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Diana LüftnerCharité University Hospital, Berlin, Campus Benjamin Franklin, Department of Hematology, Oncolo0gy and Tumour Immunology, Berlin, Germany.
Matthias W BeckmannErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany.
Erik BellevilleClinSol GmbH & Co KG, Würzburg, Germany.
Peter A FaschingErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany. Electronic address: peter.fasching@uk-erlangen.de.
Tanja N FehmDepartment of Gynecology and Obstetrics, Düsseldorf University Hospital, Germany.
Matthias GeberthGynäkologische Praxisklinik am Rosengarten, Mannheim, Germany.
Lothar HäberleErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Erlangen, Germany.
Peyman HadjiFrankfurt Center of Bone Health Frankfurt, Germany.
Andreas D HartkopfDepartment of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
Carsten HielschergSUND Gynäkologie Kompetenzzentrum Stralsund, Stralsund, Germany.
Jens HuoberDepartment of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
Eugen RuckhäberleDepartment of Gynecology and Obstetrics, Düsseldorf University Hospital, Germany.
Wolfgang JanniDepartment of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
Hans Christian KolbergMarienhospital Bottrop, Bottrop, Germany.
Christian M KurbacherGynecology I (Gynecologic Oncology), Gynäkologisches Zentrum Bonn Friedensplatz, Bonn, Germany.
Evelyn KleinDepartment of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Michael P LuxErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany.
Volkmar MüllerDepartment of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
Naiba NabievaErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany.
Friedrich OverkampOncologianova GmbH, Recklinghausen, Germany.
Hans TeschOncology Practice at Bethanien Hospital, Frankfurt, Germany.
Elena LaakmannDepartment of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
Florin-Andrei TaranDepartment of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
Julia SeitzNational Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Christoph ThomssenDepartment of Gynecology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany.
Michael UntchDepartment of Gynecology and Obstetrics, Helios Clinics Berlin Buch, Berlin, Germany.
Pauline WimbergerNational Center for Tumor Diseases and Department of Gynecology and Obstetrics, Dresden University Hospital, Dresden, Germany.
Rachel WuerstleinDepartment of Gynecology and Obstetrics, Breast Center, and CCC Munich, Munich University Hospital, Germany.
Bernhard VolzErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany.
Diethelm WallwienerDepartment of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
Markus WallwienerDepartment of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Sara Y BruckerDepartment of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33413981
PMCPMC7878444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.